Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Takeda
Company Monitoring Page for Takeda
latest headlines for company on cafepharma
Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Mon, 08/2/21 - 09:40 pm
Tags:
Takeda
,
AbbVie
,
Shire
,
taxes
,
M&A
Takeda allies with Frazier to spin out late-phase norovirus vaccine
Fierce Biotech
Fri, 07/30/21 - 11:09 am
Tags:
Takeda
,
HilleVax
,
Frazier Healthcare
,
vaccines
,
norovirus
Takeda fleshes out CNS pact with peptide drugmaker, setting aside $3.5B in future milestones
Endpoints
Tue, 07/27/21 - 10:31 am
Tags:
Takeda
,
CNS
,
peptides
,
Japan
,
PeptiDream
Takeda lays out $126M to tap robotics, virtual reality and more at California production site
Fierce Pharma
Sun, 07/25/21 - 11:47 am
Tags:
Takeda
,
California
,
robotics
,
Medtech
,
devices
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:05 am
Tags:
patents
,
patent cliff
,
AbbVie
,
Humira
,
Merck
,
Keytruda
,
Bristol Myers Squibb
,
Revlimid
,
Pfizer
,
Eliquis
,
Regeneron
,
Eylea
,
JNJ
,
Stelara
,
Opdivo
,
GSK
,
Dolutegravir
,
Ibrance
,
Januvia
,
Eli Lilly
,
Trulicity
,
Novo Nordisk
,
Victoza
,
Amgen
,
Prolia
,
Xgeva
,
Novartis
,
Cosentyx
,
Takeda
,
Entyvio
Boehringer, Lilly and Takeda join matchmaker PharmStars' digital health accelerator
Fierce Pharma
Wed, 06/16/21 - 11:50 am
Tags:
PharmStars
,
digital health
,
accelerators
,
Takeda
,
Eli Lilly
,
Boehringer Ingelheim
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
Tags:
drug development
,
MannKind
,
Thirona Bio
,
pulmonary fibrosis
,
Oyster Point Pharma
,
Adaptive Phage Therapeutics
,
ophthalmic
,
Takeda
,
Codexis
,
ALX Oncology
,
Eli Lilly
,
clinical trials
,
BeiGene
,
Shoreline Biosciences
,
oncology
After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccine
Pharmaforum
Mon, 05/24/21 - 10:55 am
Tags:
Takeda
,
clinical trials
,
vaccines
,
dengue
,
Sanofi
,
Dengvaxia
,
TAK-003
FDA Accepts NDA for Takeda’s Maribavir
BioSpace
Sun, 05/23/21 - 02:56 pm
Tags:
Takeda
,
post-transplant cytomegalovirus
,
CMV
,
maribavir
,
FDA
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Endpoints
Fri, 05/21/21 - 10:51 am
Tags:
Shire
,
Takeda
,
M&A
,
CMV
,
maribavir
Takeda fleshes out case for oral EGFR drug with follow-up pivotal data in non-small cell lung cancer
Endpoints
Wed, 05/19/21 - 11:14 pm
Tags:
ASCO 2021
,
lung cancer
,
Takeda
,
FDA
,
non-small cell lung cancer
Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict
Fierce Pharma
Wed, 05/19/21 - 11:05 pm
Tags:
Baxalta
,
Takeda
,
hemophilia
,
patents
,
Bayer
,
Adynovate
With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO
Fierce Pharma
Tue, 05/11/21 - 11:15 am
Tags:
Takeda
,
debt
,
Pharma CEOs
,
Chris Weber
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
Tags:
funding
,
venture funding
,
venture capital
,
AbbVie
,
Amgen
,
Boehringer Ingelheim
,
Bristol Myers Squibb
,
Eli Lilly
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Pfizer
,
Roche
,
Sanofi
,
Takeda
2,400 people remain without rare disease drug as Takeda manufacturing woes continue
Endpoints
Mon, 04/5/21 - 02:55 pm
Tags:
Takeda
,
hypoparathyroidism
,
drug manufacturing
,
Natpara
Takeda, CSL to end alliance as plasma-based COVID-19 drug fails key test
BioPharma Dive
Mon, 04/5/21 - 02:43 pm
Tags:
Takeda
,
CSL Behring
,
COVID-19
Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
Pharmaceutical Business Review
Thu, 04/1/21 - 10:50 am
Tags:
Takeda
,
OTC
,
M&A
,
Orifarm
Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness push
Fierce Pharma
Wed, 03/31/21 - 10:49 am
Tags:
Takeda
,
eosinophilic esophagitis
,
drug marketing
Takeda taps BridGene to pursue hard-to-drug neurodegenerative disease targets
Fierce Biotech
Tue, 03/30/21 - 11:38 am
Tags:
Takeda
,
BridGene Biosciences
,
small molecule drugs
,
neurodegenerative disease
Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases
NASDAQ
Thu, 03/18/21 - 11:06 am
Tags:
Takeda
,
AnimaBiotech
,
MRNA
,
drug development
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.